Gene · 3015
Papers2,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic Mechanisms of Aging and Aging-Associated Diseases. | Cells | 2023 | 37190071 | PubTator, text mining | PubMed |
| Sites of transcription initiation drive mRNA isoform selection. | Cell | 2023 | 37178687 | PubTator, text mining | PubMed |
| Mutual Regulation of ncRNAs and Chromatin Remodeling Complexes in Normal and Pathological Conditions. | Int J Mol Sci | 2023 | 37175555 | PubTator, text mining | PubMed |
| Cis-regulatory atlas of primary human CD4+ T cells. | BMC Genomics | 2023 | 37170195 | PubTator, text mining | PubMed |
| Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes. | Nat Commun | 2023 | 37169774 | PubTator, text mining | PubMed |
| Histone chaperones AtChz1A and AtChz1B are required for H2A.Z deposition and interact with the SWR1 chromatin-remodeling complex in Arabidopsis thaliana. | New Phytol | 2023 | 37129076 | PubTator, text mining | PubMed |
| PGE2 alters chromatin through H2A.Z-variant enhancer nucleosome modification to promote hematopoietic stem cell fate. | Proc Natl Acad Sci U S A | 2023 | 37126722 | PubTator, text mining | PubMed |
| Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer. | World J Gastroenterol | 2023 | 37124888 | PubTator, text mining | PubMed |
| A review on the role of LINC00511 in cancer. | Front Genet | 2023 | 37124625 | PubTator, text mining | PubMed |
| Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults. | Nat Aging | 2023 | 37117789 | PubTator, text mining | PubMed |
| An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review. | Genes (Basel) | 2023 | 37107631 | PubTator, text mining | PubMed |
| JAZF1: A metabolic actor subunit of the NuA4/TIP60 chromatin modifying complex. | Front Cell Dev Biol | 2023 | 37091973 | PubTator, text mining | PubMed |
| Molecular characterization of colorectal mucinous adenocarcinoma and adenocarcinoma, not otherwise specified, identified by multiomic data analysis. | Front Mol Biosci | 2023 | 37091868 | PubTator, text mining | PubMed |
| RUVBL1-modulated chromatin remodeling alters the transcriptional activity of oncogenic CTNNB1 in uveal melanoma. | Cell Death Discov | 2023 | 37076452 | PubTator, text mining | PubMed |
| LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization. | J Exp Clin Cancer Res | 2023 | 37072811 | PubTator, text mining | PubMed |
| Emerging evidence that the mammalian sperm epigenome serves as a template for embryo development. | Nat Commun | 2023 | 37059740 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37059591 | PubTator, text mining | PubMed |
| The esBAF and ISWI nucleosome remodeling complexes influence occupancy of overlapping dinucleosomes and fragile nucleosomes in murine embryonic stem cells. | BMC Genomics | 2023 | 37055726 | PubTator, text mining | PubMed |
| AP2α negatively regulates PDHA1 in cervical cancer cells to promote aggressive features and aerobic glycolysis in vitro and in vivo. | J Gynecol Oncol | 2023 | 37055163 | PubTator, text mining | PubMed |
| Cell-Free RNA from Plasma in Patients with Neuroblastoma: Exploring the Technical and Clinical Potential. | Cancers (Basel) | 2023 | 37046768 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3015/papers?page=17